MANEVSMRNA• 12 Months (Normalized)
MANE vs MRNA (Veradermics Incorporated vs Moderna Inc.)
Showing Closing Date Range from Oct 5, 2025 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MANE Performance $116.76
+209.3%
Veradermics Incorporated
Normalized Baseline0.00%
MRNA Performance $190.01
+589.94%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-380.64 pts
MRNA outperforming by 380.64 percentage points
MANEMRNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MANE MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | MANE Price | MANE Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $116.76 | +209.30% | $190.01 | +589.94% | -380.64% |
| Oct 01, 2026 | $- | $188.94 | +586.06% | - | |
| Sep 30, 2026 | $- | $192.57 | +599.24% | - | |
| Sep 29, 2026 | $- | $203.46 | +638.78% | - | |
| Sep 28, 2026 | $- | $197.28 | +616.34% | - | |
| Sep 25, 2026 | $- | $198.88 | +622.15% | - | |
| Sep 24, 2026 | $115.72 | +206.54% | $- | - | |
| Sep 23, 2026 | $115.78 | +206.70% | $182.11 | +561.26% | -354.56% |
| Sep 22, 2026 | $118.14 | +212.95% | $182.56 | +562.89% | -349.94% |
| Sep 21, 2026 | $112.80 | +198.81% | $172.94 | +527.96% | -329.15% |
| Sep 18, 2026 | $106.75 | +182.78% | $154.04 | +459.33% | -276.55% |
| Sep 17, 2026 | $108.68 | +187.89% | $158.07 | +473.97% | -286.08% |
| Sep 16, 2026 | $102.42 | +171.31% | $145.62 | +428.76% | -257.45% |
| Sep 15, 2026 | $103.89 | +175.21% | $143.77 | +422.04% | -246.83% |
| Sep 14, 2026 | $101.70 | +169.40% | $146.69 | +432.64% | -263.24% |
Page 1 of 17